版本:
中国

BRIEF-Moleculin Biotech Qtrly net loss per share $0.02

May 15 Moleculin Biotech Inc:

* Moleculin Biotech, Inc. Reports financial results for the first quarter ended march 31, 2017

* As of March 31, 2017, company had $8.88 million of cash and cash equivalents compared to $5.00 million at december 31, 2016

* Qtrly net loss per share $0.02

* Company believes it will be able to publicly announce results from its phase i/ii clinical trial sometime in 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐